NeuroEchos
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- Undisclosed
Investors
- 3
About NeuroEchos
Based in Shenzhen, China and established in 2017, NeuroEchos is a medical equipment distributor that provides brain electrode hardware and relate AI software. The company's treatment products can be categorized into electrode products for epilepsy diagnosis, and laser ablation products for epilepsy treatment. Its electrode products can realize the acquisition, analysis and diagnosis of high frequency nerve discharge signal. Its AI software can assist in improving the efficiency of EEG monitor and recognition.
Who invested in NeuroEchos
3 investors across 1 round
See all investors in NeuroEchos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 22, 2022
Amount
Undisclosed
Investors
Questions about NeuroEchos
Who invested in NeuroEchos?
NeuroEchos has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroEchos raised?
NeuroEchos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuroEchos last raise money?
NeuroEchos's most recent round on record is a Series A, in Feb 2022.
What does NeuroEchos do?
Based in Shenzhen, China and established in 2017, NeuroEchos is a medical equipment distributor that provides brain electrode hardware and relate AI software.
Where is NeuroEchos headquartered?
NeuroEchos is headquartered in Shenzhen, China.
Which VCs invest in companies like NeuroEchos?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at NeuroEchos's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like NeuroEchos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.